Monthly Archives: February 2018

///February

Cellect Announces Breakthrough Clinical Results

First Group of Patients in Clinical Trial With Cellect's ApoGraft Stem Cell Transplant Follow up Results 100% Acceptance and Zero Related Adverse Events Dr. Shai Yarkoni, Cellect CEO commented: "These interim results further support that we are closer than ever to a world where stem cells are used to replace sick organs and damaged tissues." [...]

By |2018-11-20T10:03:29+00:00February 21st, 2018|Blog|Comments Off on Cellect Announces Breakthrough Clinical Results

Why Israel rocks at commercializing academic innovations

Universities worldwide are looking to emulate Israel’s tech-transfer magic. By Abigail Klein Leichman It’s no coincidence that Harvard and UCLA chose experienced Israelis to direct their technology-transfer offices. Cash-strapped universities urgently need to streamline the transfer of inventions from lab bench to market, and Israeli TTOs have a remarkable track record of generating more revenue [...]

By |2018-11-20T10:03:52+00:00February 21st, 2018|Blog|Comments Off on Why Israel rocks at commercializing academic innovations

THE POMEGRANATE POTENTIAL

An innovative Israeli supplement for preventing and improving neurodegenerative diseases is here. BY JUDY SIEGEL-ITZKOVI   Pomegranates are known to contain powerful antioxidants that fight the oxygen free radicals that cause inflammation, accelerated aging of the tissues, the activation of harmful genes within DNA and an overloaded immune system. Various herbs, spices such as turmeric [...]

By |2018-11-20T10:04:32+00:00February 21st, 2018|Blog|Comments Off on THE POMEGRANATE POTENTIAL

Diagnostics co MeMed awarded $4m US Defense Dept grant

Israeli immune based diagnostics company MeMed announced that it has been awarded a $4 million grant by the US Department of Defense's Congressionally Directed Medical Research Programs (CDMRP). The award will support transition of the Tirat Hacarmel-based company's prototype point-of-care (POC) platform towards a final product, including transfer to manufacturing and implementation of cloud connectivity. The [...]

By |2018-11-20T10:05:53+00:00February 20th, 2018|Blog|Comments Off on Diagnostics co MeMed awarded $4m US Defense Dept grant

Israel innovation makes up half of Merck healthcare revenue, top official says

  Kai Beckmann, CEO of Performance Materials at Merck, says 'our collaboration has deep roots' as the German pharma and chemical giant expands Jerusalem lab By SHOSHANNA SOLOMON Israeli innovation is behind almost half of the healthcare revenues of the 350-year-old German pharmaceutical and chemicals firm Merck, Kai Beckmann, CEO of Performance Materials at the [...]

By |2018-11-20T10:06:03+00:00February 20th, 2018|Blog|Comments Off on Israel innovation makes up half of Merck healthcare revenue, top official says

ALYNnovation: ‘Impossible’ is not in our vocabulary

  ALYNnovation takes medical innovations developed at the ALYN pediatric rehabilitation hospital out of the hospital so that all children can benefit from them. Although most children on respirators are also paralyzed, they can derive a great deal of benefit from treatment with water. The problem is that their respirator must not become wet. "Our [...]

By |2018-11-20T10:06:19+00:00February 20th, 2018|Blog|Comments Off on ALYNnovation: ‘Impossible’ is not in our vocabulary

Preliminary Speakers of MIXiii-Biomed 2018

    MIXiii-Biomed 2018 Conference - Innovation and Trends shaping the future of healthcare systems and life sciences Following in the tradition of the Biomed Israel Conferences, the scientific program is of a high standard. The conference is co-organized by leading Israeli and international healthcare institutions with the objective of exposing participants to thought leaders [...]

By |2018-02-27T11:42:01+00:00February 8th, 2018|News|Comments Off on Preliminary Speakers of MIXiii-Biomed 2018